The Apomediary [Patient Expert] and Personalized Medicine: A Commentary

June 22, 2014 – The individuum (i.e., patient) is the phenotype expert on her/his individualized form of proper disease she/he is suffering from. It is not her/his treating physician, it is not a regulatory person concerned with the safety and efficacy of the medication geared towards treating her/his condition, and for sure it is not the marketing person at the pharmaceutical company which is the manufacturer of the medication.

More than ever you are the expert on your individualized form of your disease and how you react to the medication you take to alleviate your disease. You have become an apomediary, that is a peer who has become an expert.

Your phenotypic reactions towards a medication (e.g., shrinking of your particular tumor, or developing a serious skin reaction) depend on a number of factors. Some of these factors may be genetic, some are molecular, and some may be confounding.

Generally speaking, genetic factors will most probably be the most decisive factors that determine just what type (form) of disease you exactly suffer from, and/or govern your individual response towards a medication you take.

Confounding factors may be your normal habits, your dieting habits, your social drinking habits, your body mass index, your co-medications, your co- morbidities, your gender, and your age, to name just a few.

Even though we talk about (highly) individualized and personalized medicine, and even though you as a patient might have the feeling that you are the only one with your individualized form of disease and/or the treatment you receive is very unique to you, you are not alone.

Nature has it that decisive genetic, molecular, and confounding factors that govern your disease behaviour and treatment responses occur with certain frequencies in populations, some with high (e.g., one in ten individuals), some with very low (e.g., one in a million individuals) frequencies. Chances are that somewhere out there, there is a fellow patient of yours with the same set as yours of genetic, molecular, and confounding factors. Chances are that this fellow patient will largely behave just like you towards the same disease of yours. In fact, all fellow patients carrying the same set of disease behaviour determining factors will behave largely alike. One could say that all these fellow patients share the same destiny based on their indentical genetic, molecular, and confounding factors, falling into a (sub)group of patients with very similar behavior towards the respective disease and/or medication. Fellow patient members of such groups may be located at any place globally seen, and speak any one of the many languages worldwide.

Absolutely flabbergasting new developments in the area of mobile and wearable diagnostic devices, which actually record values on vital functions and of (blood) chemistry in individual patients will shortly help to further the recognition of subgroups of fellow patients whose vital signs, phenotypic behaviors, and genetic backgrounds fall together.

Eventually, thasso should facilitate the crowdsourcing and sharing of the collective wisdom within such patient subgroups (communities) in a mobile fashion, around the clock, and completely independent of the geolocation of the fellow patient member. In the process, the level of partizipation and the control over it remains with the individual. You may decide to just follow the online activities of fellow patients, or you may decide to share parts or all of your electronic medical record (EMR) with your fellow patients. It’s up to you, the individual (patient).

Tags: , , , , , , , , , , , , , ,
About the Author
Joseph Gut - thasso Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.
1 Pings/Trackbacks for "The Apomediary [Patient Expert] and Personalized Medicine: A Commentary"

Your opinion


No comments yet

thasso: conditions

thasso: newest tweets

thasso: recent comments

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Nurse practitioners play key role in opioid addiction treatment in very rural areas November 23, 2020
    Giving nurse practitioners the authority to prescribe buprenorphine has brought that gold standard treatment for opioid addiction to people who might not have had access to it before, according to a new study. Looking at prescription drug monitoring data in Oregon before and after 2017, when nurse practitioners and physician assistants gained the authority to […]
  • Identical evolution of isolated organisms November 23, 2020
    Palaeontologists at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and the University of Calgary in Canada have provided new proof of parallel evolution: conodonts, early vertebrates from the Permian period, adapted to new habitats in almost identical ways despite living in different geographical regions. The researchers were able to prove that this was the case using fossil teeth found […]
  • A chemist from RUDN University synthesized analogs of natural toxins November 23, 2020
    A chemist from RUDN University suggested a simple and accurate method for the synthesis of analogs of two natural toxins, antofine and septicine. This universal approach can also be used to obtain other biologically active substances for medicinal chemistry.
  • Researchers minimize quantum backaction in thermodynamic systems via entangled measurement November 23, 2020
    Researchers from University of Science and Technology of China theoretically proved that the backaction can be suppressed to zero in a two qubit system, and conducted the first experiment using entangled collective measurement for minimizing quantum measurement backaction based on photonic system.
  • Growing risks of STIs in over-45s November 23, 2020
    Sexually-active over-45s are at a high risk of contracting STIs because people do not want to talk about holder people having sex, a report has found.